Literature DB >> 11350535

Minimization in crossover trials with non-prognostic strata: theory and practical application.

H Green1, D J McEntegart, B Byrom, S Ghani, S Shepherd.   

Abstract

To obtain meaningful results in any clinical trial, patients need to be allocated to treatments in such a way that valid analysis can be carried out. Balancing treatment groups before analysis is carried out is more desirable than trying to compensate for incomparability at a later date. Therefore, the development of allocation procedures to produce comparable groups in which prognostic factors are equally represented is important. Minimization, a deterministic allocation method, aims to ensure balance on such factors, particularly in small trials when traditional randomization methods are likely to fail. However, views on the use of conventional analysis following minimization are divided. The use of minimization in two randomised crossover trials is described where, in addition to the comparisons between randomised treatments, it was desired to have balance between groups based on differential trial procedures. Theoretical concerns about the use of minimization are not applicable in this setting, and therefore minimization is shown to be a useful technique for obtaining balance.

Entities:  

Mesh:

Year:  2001        PMID: 11350535     DOI: 10.1046/j.1365-2710.2001.00332.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  7 in total

1.  A simulation study of the validity and efficiency of design-adaptive allocation to two groups in the regression situation.

Authors:  Mikel Aickin
Journal:  Int J Biostat       Date:  2009-05-29       Impact factor: 0.968

2.  Randomization in clinical trials: stratification or minimization? The HERMES free simulation software.

Authors:  Hélène Fron Chabouis; Francis Chabouis; Florence Gillaizeau; Pierre Durieux; Gilles Chatellier; N Dorin Ruse; Jean-Pierre Attal
Journal:  Clin Oral Investig       Date:  2013-03-01       Impact factor: 3.573

3.  High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.

Authors:  Cédric Annweiler; Mélinda Beaudenon; Jennifer Gautier; Justine Gonsard; Sophie Boucher; Guillaume Chapelet; Astrid Darsonval; Bertrand Fougère; Olivier Guérin; Marjorie Houvet; Pierre Ménager; Claire Roubaud-Baudron; Achille Tchalla; Jean-Claude Souberbielle; Jérémie Riou; Elsa Parot-Schinkel; Thomas Célarier
Journal:  PLoS Med       Date:  2022-05-31       Impact factor: 11.613

4.  Feasibility study of short-term effects of chiropractic manipulation on older adults with impaired balance.

Authors:  Cheryl Hawk; Mark T Pfefer; Richard Strunk; Michael Ramcharan; Nathan Uhl
Journal:  J Chiropr Med       Date:  2007-12

5.  Minimal sufficient balance randomization for sequential randomized controlled trial designs: results from the ESCAPE trial.

Authors:  Tolulope T Sajobi; Gurbakhshash Singh; Mark W Lowerison; Jordan Engbers; Bijoy K Menon; Andrew M Demchuk; Mayank Goyal; Michael D Hill
Journal:  Trials       Date:  2017-11-02       Impact factor: 2.279

6.  Development of a minimization instrument for allocation of a hospital-level performance improvement intervention to reduce waiting times in Ontario emergency departments.

Authors:  Chad Andrew Leaver; Astrid Guttmann; Merrick Zwarenstein; Brian H Rowe; Geoff Anderson; Therese Stukel; Brian Golden; Robert Bell; Dante Morra; Howard Abrams; Michael J Schull
Journal:  Implement Sci       Date:  2009-06-08       Impact factor: 7.327

7.  Balance algorithm for cluster randomized trials.

Authors:  Ben R Carter; Kerenza Hood
Journal:  BMC Med Res Methodol       Date:  2008-10-09       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.